<p>ADC Therapeutics SA has granted options to purchase a total of 308,000 common shares to seven new employees. The options will vest 25% on the first anniversary of the grant date, with the remaining shares vesting in equal monthly installments over the following three years, becoming fully vested after four years, contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADC Therapeutics SA published the original content used to generate this news brief on February 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

Reuters

VanEck Biotech ETF

Health Care Select Sector SPDR

Proshares Ultra Nasdaq Biotech

iShares US Pharma

Invesco Nasdaq Biotechnology ETF

SPDR S&P Biotech

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

iShares Global Healthcare

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

VG Health

ADC Therapeutics SA

Ark Genomic Revolution ETF

ADC Therapeutics Grants Stock Options to New Employees Under Inducement Plan